Theravance Biopharma, Inc. - Ordinary Share $0.00001 par value (TBPH)

CUSIP: G8807B106

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / Ordinary Share $0.00001 par value
Shares outstanding
50,588,235
Total 13F shares
62,986,284
Share change
+3,508,620
Total reported value
$602,166,380
Put/Call ratio
377%
Price per share
$9.56
Number of holders
114
Value change
+$31,622,746
Number of buys
56
Number of sells
50

Quarterly Holders Quick Answers

What is CUSIP G8807B106?
CUSIP G8807B106 identifies TBPH - Theravance Biopharma, Inc. - Ordinary Share $0.00001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Theravance Biopharma, Inc. - Ordinary Share $0.00001 par value (TBPH) as of Q1 2022

As of 31 Mar 2022, Theravance Biopharma, Inc. - Ordinary Share $0.00001 par value (TBPH) was held by 114 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 62,986,284 shares. The largest 10 holders included BAUPOST GROUP LLC/MA, Madison Avenue Partners, LP, VANGUARD GROUP INC, Weiss Asset Management LP, BlackRock Inc., ORBIMED ADVISORS LLC, FMR LLC, STATE STREET CORP, Newtyn Management, LLC, and Woodline Partners LP. This page lists 114 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.